Nevro Corp (NVRO)
5.33
-0.45
(-7.79%)
USD |
NYSE |
Nov 07, 16:00
5.33
0.00 (0.00%)
After-Hours: 20:00
Nevro Revenue (Annual): 425.17M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 425.17M |
| December 31, 2022 | 406.36M |
| December 31, 2021 | 386.90M |
| December 31, 2020 | 362.05M |
| December 31, 2019 | 390.26M |
| December 31, 2018 | 387.29M |
| Date | Value |
|---|---|
| December 31, 2017 | 326.67M |
| December 31, 2016 | 228.50M |
| December 31, 2015 | 69.61M |
| December 31, 2014 | 32.57M |
| December 31, 2013 | 23.50M |
| December 31, 2012 | 18.15M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
362.05M
Minimum
2020
425.17M
Maximum
2023
394.15M
Average
390.26M
Median
2019
Revenue (Annual) Benchmarks
| Myomo Inc | 19.24M |
| Cutera Inc | 212.37M |
| IRIDEX Corp | 51.87M |
| Stereotaxis Inc | 26.77M |
| Electromed Inc | 54.72M |